Evaluation of Epsilon amino-caproic acid (EACA) and autologous blood as blood conservation strategies in patients undergoing cardiac surgery

Heart Lung Circ. 2006 Aug;15(4):261-5. doi: 10.1016/j.hlc.2006.03.014. Epub 2006 May 12.

Abstract

Background: To evaluate the effects of autologous blood and Epsilon amino-caproic acid on intra-operative and post-operative blood loss and homologous blood product requirements in patients undergoing cardiac surgery.

Methods: Patients were randomly allocated to two groups of 30 each. In the Epsilon amino-caproic acid (EACA) group, the drug was administered in a loading dose of 100 mg/kg before skin incision followed by an infusion of 1/5 th the loading dose hourly and terminated 3 h after heparin neutralization. In the autologous transfusion (AT) group, 10% of the calculated whole blood volume was collected intra-operatively before cardiopulmonary bypass and re-infused after its termination.

Results: Haemoglobin values were comparable pre-operatively, on cardiopulmonary bypass, off cardiopulmonary bypass and post-operatively on day two in both groups. Intra-operative blood loss was not significantly different (643.3+/-129.14 ml in group EACA versus 710+/-145.5 ml in group AT, p = 0.66). Although the chest drainage was more in group AT during 0-3 h (71.3+/-54.3 ml versus 112.6+/-79.3.6 ml, p = 0.006) it was comparable amongst in the first 24 h (231.1+/-98.3 ml in group AT versus 235+/-101.4 ml in group EACA, p = 0.88). Homologous blood product requirements were similar in both groups.

Conclusion: Autologous blood is as efficacious as Epsilon amino-caproic acid for blood conservation in cardiac surgery.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aminocaproic Acid / therapeutic use*
  • Antifibrinolytic Agents / therapeutic use*
  • Blood Loss, Surgical / physiopathology
  • Blood Loss, Surgical / prevention & control*
  • Blood Transfusion, Autologous*
  • Blood Volume / physiology
  • Cardiac Surgical Procedures
  • Cardiopulmonary Bypass / methods
  • Female
  • Hemostasis, Surgical / methods*
  • Humans
  • Male
  • Middle Aged
  • Postoperative Hemorrhage / physiopathology
  • Postoperative Hemorrhage / prevention & control*

Substances

  • Antifibrinolytic Agents
  • Aminocaproic Acid